MOGAMULIZUMAB-KPKC

MOGAMULIZUMAB-KPKC was reported 1361 times

MOGAMULIZUMAB-KPKC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RADIOTHERAPY TO TONGUE 1 1.0000
1 SEZARY CELLS INCREASED 2 0.2500
2 CUTANEOUS T-CELL LYMPHOMA RECURRENT 5 0.0794
3 AUTOIMMUNE VASCULITIS 1 0.0588
4 LYMPHODEPLETION 2 0.0588
5 PHOTOPHERESIS 1 0.0556
6 PSEUDOMONAL SKIN INFECTION 1 0.0417
7 LISTERAEMIA 1 0.0400
8 IMMUNOLOGY TEST 1 0.0370
9 THERAPY NAIVE 4 0.0323
10 HISTOPLASMOSIS CUTANEOUS 1 0.0208
11 CYTOMEGALOVIRUS ENTERITIS 7 0.0197
12 TERTIARY ADRENAL INSUFFICIENCY 1 0.0185
13 BLOOD CREATINE PHOSPHOKINASE MB ABNORMAL 1 0.0185
14 CD8 LYMPHOCYTES INCREASED 1 0.0161
15 PLAGUE 1 0.0149
16 OESOPHAGITIS CHEMICAL 1 0.0149
17 ERYTHEMA ANNULARE 4 0.0138
18 AUTOIMMUNE DERMATITIS 2 0.0132
19 RASH PAPULOSQUAMOUS 2 0.0132
20 ANAL FUNGAL INFECTION 1 0.0120
21 BULBAR PALSY 3 0.0108
22 ALPHA TUMOUR NECROSIS FACTOR INCREASED 1 0.0108
23 EOSINOPHILIC PUSTULAR FOLLICULITIS 1 0.0108
24 TUMOUR FLARE 7 0.0102
25 BENIGN LYMPH NODE NEOPLASM 1 0.0102
26 CUTANEOUS LYMPHOMA 2 0.0098
27 POIKILODERMA 1 0.0093
28 AUTOIMMUNE THYROID DISORDER 1 0.0092
29 CYTOMEGALOVIRUS ENTEROCOLITIS 7 0.0091
30 NODULAR RASH 2 0.0090
31 LISTERIA ENCEPHALITIS 1 0.0088
32 PNEUMOCOCCAL INFECTION 5 0.0084
33 LYMPHOMA TRANSFORMATION 3 0.0083
34 ACHROMOBACTER INFECTION 1 0.0083
35 SUPERFICIAL INFLAMMATORY DERMATOSIS 1 0.0081
36 INFECTED NEOPLASM 2 0.0080
37 PELVIC DEFORMITY 1 0.0078
38 ATYPICAL MYCOBACTERIAL PNEUMONIA 1 0.0072
39 CUTANEOUS T-CELL LYMPHOMA 9 0.0071
40 CRANIAL NERVE PALSIES MULTIPLE 1 0.0071
41 PERINEAL ULCERATION 1 0.0071
42 ENGRAFT FAILURE 2 0.0070
43 ABDOMINAL WALL WOUND 1 0.0065
44 GASTROENTERITIS STAPHYLOCOCCAL 1 0.0064
45 TUMOUR INVASION 3 0.0062
46 ALOPECIA TOTALIS 2 0.0061
47 SEPTIC ENCEPHALOPATHY 1 0.0058
48 BLOOD LACTIC ACID DECREASED 1 0.0058
49 VITILIGO 13 0.0055
50 ALOPECIA SCARRING 1 0.0055
51 CYTOMEGALOVIRUS OESOPHAGITIS 2 0.0054
52 T-LYMPHOCYTE COUNT INCREASED 1 0.0054
53 MYCOTIC ENDOPHTHALMITIS 1 0.0053
54 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0053
55 KERATITIS FUNGAL 1 0.0048
56 THYROXINE ABNORMAL 1 0.0047
57 DRUG ERUPTION 81 0.0046
58 AUTOIMMUNE NEPHRITIS 1 0.0045
59 HERPES ZOSTER CUTANEOUS DISSEMINATED 1 0.0043
60 TUMOUR ULCERATION 1 0.0042
61 GRANULOMATOUS DERMATITIS 1 0.0041
62 ICHTHYOSIS 1 0.0040
63 CHRONIC DISEASE 1 0.0039
64 BACTERIAL ENDOPHTHALMITIS 1 0.0038
65 INTERLEUKIN LEVEL INCREASED 2 0.0036
66 ACUTE POLYNEUROPATHY 1 0.0035
67 DERMATITIS EXFOLIATIVE GENERALISED 12 0.0034
68 ALOPECIA UNIVERSALIS 1 0.0034
69 ENGRAFTMENT SYNDROME 2 0.0034
70 EAR INFECTION FUNGAL 1 0.0033
71 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 7 0.0033
72 INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS 1 0.0032
73 VACCINE INTERACTION 1 0.0032
74 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 1 0.0032
75 GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0032
76 RESPIRATORY MUSCLE WEAKNESS 1 0.0031
77 RESPIRATORY ALKALOSIS 5 0.0031
78 GRAFT VERSUS HOST DISEASE 22 0.0031
79 ACUTE HEPATITIS B 1 0.0030
80 ECTROPION 1 0.0030
81 URETERAL STENT INSERTION 1 0.0029
82 ALOPECIA AREATA 5 0.0028
83 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 4 0.0028
84 SPINAL CORD OEDEMA 1 0.0027
85 AORTIC RUPTURE 1 0.0026
86 PNEUMONIA CYTOMEGALOVIRAL 5 0.0026
87 HUMIDITY INTOLERANCE 1 0.0025
88 ECTHYMA 1 0.0025
89 SQUAMOUS CELL CARCINOMA OF THE TONGUE 1 0.0024
90 GRANULOMA SKIN 2 0.0024
91 LICHENIFICATION 1 0.0024
92 LYMPHOPENIA 34 0.0024
93 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
94 GLUCOCORTICOID DEFICIENCY 1 0.0024
95 TISSUE INJURY 1 0.0023
96 POSTRENAL FAILURE 1 0.0023
97 OSTOMY BAG PLACEMENT 1 0.0022
98 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 6 0.0022
99 ECZEMA HERPETICUM 1 0.0022
100 AUTOIMMUNE HEPATITIS 15 0.0022
101 CYSTOID MACULAR OEDEMA 4 0.0021
102 AUTOIMMUNE MYOSITIS 1 0.0021
103 LENTIGO 1 0.0020
104 MENINGITIS LISTERIA 1 0.0020
105 DERMATITIS PSORIASIFORM 4 0.0020
106 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
107 MOLLUSCUM CONTAGIOSUM 1 0.0019
108 HYPEREOSINOPHILIC SYNDROME 1 0.0018
109 LUNG CONSOLIDATION 5 0.0018
110 GLOMERULONEPHRITIS MEMBRANOUS 2 0.0017
111 RECTAL ADENOCARCINOMA 1 0.0017
112 GLOMERULONEPHRITIS 4 0.0016
113 STAPHYLOCOCCAL SKIN INFECTION 2 0.0016
114 MEDICAL DEVICE SITE INFECTION 1 0.0016
115 MUSCLE ABSCESS 1 0.0016
116 DRY GANGRENE 1 0.0016
117 STAPHYLOCOCCAL ABSCESS 1 0.0016
118 AUTOIMMUNE COLITIS 1 0.0016
119 MYELOPROLIFERATIVE NEOPLASM 1 0.0015
120 EMERGENCY CARE EXAMINATION 1 0.0015
121 T-LYMPHOCYTE COUNT DECREASED 1 0.0015
122 BILIARY TRACT DISORDER 2 0.0014
123 CRYOGLOBULINAEMIA 1 0.0014
124 VASCULITIS NECROTISING 1 0.0014
125 GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
126 MYOCARDITIS 16 0.0014
127 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
128 NASAL INJURY 1 0.0014
129 BACTERIAL DISEASE CARRIER 1 0.0014
130 INFUSION SITE REACTION 4 0.0013
131 MICTURITION FREQUENCY DECREASED 1 0.0013
132 MIXED LIVER INJURY 4 0.0013
133 ACUTE GRAFT VERSUS HOST DISEASE 6 0.0013
134 NEOPLASM SKIN 2 0.0013
135 PULMONARY MYCOSIS 1 0.0013
136 MYOPERICARDITIS 1 0.0013
137 SKIN NEOPLASM EXCISION 1 0.0013
138 HEPATITIS E 2 0.0013
139 SUPERINFECTION BACTERIAL 1 0.0013
140 HYPOPYON 1 0.0012
141 STARVATION 1 0.0012
142 COVID-19 IMMUNISATION 1 0.0012
143 SYSTEMIC CANDIDA 3 0.0012
144 AUTOIMMUNE HAEMOLYTIC ANAEMIA 4 0.0012
145 GRANULOMA 4 0.0012
146 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 1 0.0011
147 CYTOMEGALOVIRUS INFECTION REACTIVATION 5 0.0011
148 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
149 SKIN WEEPING 4 0.0011
150 TOXIC EPIDERMAL NECROLYSIS 17 0.0011
151 MYOSITIS 10 0.0011
152 PROTEIN URINE 1 0.0011
153 SINUS NODE DYSFUNCTION 2 0.0011
154 C-REACTIVE PROTEIN 1 0.0011
155 LUPUS NEPHRITIS 2 0.0011
156 AUTOIMMUNE THYROIDITIS 4 0.0011
157 DISEASE PROGRESSION 123 0.0010
158 THERAPY PARTIAL RESPONDER 16 0.0010
159 CYTOMEGALOVIRUS CHORIORETINITIS 2 0.0010
160 OESOPHAGEAL CANDIDIASIS 4 0.0010
161 RENAL HAEMORRHAGE 2 0.0010
162 ANAPHYLACTOID REACTION 4 0.0010
163 DIVERTICULAR PERFORATION 2 0.0010
164 SKIN PLAQUE 8 0.0009
165 TUMOUR NECROSIS 1 0.0009
166 NAIL GROWTH ABNORMAL 1 0.0009
167 SUSPECTED COVID-19 3 0.0009
168 TUMOUR LYSIS SYNDROME 8 0.0009
169 CYTOMEGALOVIRUS VIRAEMIA 4 0.0009
170 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 1 0.0009
171 ACUTE PULMONARY OEDEMA 5 0.0009
172 INFUSION RELATED REACTION 59 0.0009
173 LICHENOID KERATOSIS 2 0.0009
174 ARTERIAL HAEMORRHAGE 1 0.0009
175 PHOBIA 1 0.0009
176 MYASTHENIA GRAVIS 7 0.0009
177 RADIATION SKIN INJURY 1 0.0009
178 HEPATIC CYTOLYSIS 11 0.0009
179 LICHEN PLANUS 2 0.0009
180 RALES 5 0.0009
181 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
182 RECTAL ULCER 1 0.0009
183 FULL BLOOD COUNT INCREASED 1 0.0008
184 GRANULOMATOSIS WITH POLYANGIITIS 1 0.0008
185 ENCEPHALITIS VIRAL 1 0.0008
186 IMMUNE-MEDIATED ENTEROCOLITIS 3 0.0008
187 ORAL MUCOSA EROSION 1 0.0008
188 SKIN DISORDER 27 0.0008
189 XEROSIS 1 0.0008
190 PERIPHERAL SENSORIMOTOR NEUROPATHY 1 0.0008
191 NOCARDIOSIS 2 0.0008
192 BLOOD BILIRUBIN ABNORMAL 1 0.0008
193 ANGINA UNSTABLE 5 0.0008
194 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
195 NEUROMYELITIS OPTICA SPECTRUM DISORDER 1 0.0007
196 MUCOUS MEMBRANE DISORDER 1 0.0007
197 SKIN LESION 20 0.0007
198 CENTRAL NERVOUS SYSTEM LYMPHOMA 1 0.0007
199 VIRAEMIA 1 0.0007
200 NAIL INFECTION 1 0.0007
201 TOXIC SKIN ERUPTION 7 0.0007
202 ADENOVIRUS INFECTION 2 0.0007
203 STRESS CARDIOMYOPATHY 4 0.0007
204 CHOLANGIOCARCINOMA 1 0.0007
205 INFECTIOUS PLEURAL EFFUSION 1 0.0007
206 PNEUMONIA PSEUDOMONAL 1 0.0007
207 IMMUNE-MEDIATED ADVERSE REACTION 1 0.0007
208 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
209 OPHTHALMOPLEGIA 1 0.0006
210 TINEA PEDIS 1 0.0006
211 NIGHT BLINDNESS 1 0.0006
212 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1 0.0006
213 STUPOR 2 0.0006
214 CRYPTOCOCCOSIS 1 0.0006
215 LYMPHOCYTE COUNT INCREASED 2 0.0006
216 IGA NEPHROPATHY 1 0.0006
217 NEPHRITIS 2 0.0006
218 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
219 COVID-19 PNEUMONIA 7 0.0006
220 TYMPANIC MEMBRANE PERFORATION 1 0.0006
221 EXPOSURE TO SARS-COV-2 1 0.0006
222 GLIOBLASTOMA 1 0.0006
223 NEPHROTIC SYNDROME 4 0.0006
224 RETINITIS 1 0.0006
225 SKIN NECROSIS 3 0.0006
226 PSEUDOMONAL SEPSIS 1 0.0006
227 POLYARTHRITIS 3 0.0006
228 HYPERCALCAEMIA 7 0.0006
229 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1 0.0006
230 SKIN HYPOPIGMENTATION 1 0.0006
231 POLYMYOSITIS 1 0.0006
232 PARAPARESIS 1 0.0006
233 CONJUNCTIVAL HYPERAEMIA 2 0.0006
234 AORTIC VALVE STENOSIS 1 0.0006
235 CHRONIC GRAFT VERSUS HOST DISEASE 2 0.0006
236 OPPORTUNISTIC INFECTION 1 0.0005
237 VITRITIS 1 0.0005
238 STEVENS-JOHNSON SYNDROME 12 0.0005
239 LYMPH NODE PAIN 1 0.0005
240 WHITE BLOOD CELLS URINE POSITIVE 1 0.0005
241 SKIN TOXICITY 3 0.0005
242 INTERVERTEBRAL DISCITIS 1 0.0005
243 PEMPHIGOID 4 0.0005
244 ADVERSE REACTION 7 0.0005
245 HYPOPROTEINAEMIA 1 0.0005
246 TONGUE OEDEMA 2 0.0005
247 RADIOTHERAPY 1 0.0005
248 NEOPLASM 6 0.0005
249 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
250 PROCEDURAL HAEMORRHAGE 2 0.0005
251 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
252 BRADYKINESIA 3 0.0005
253 CARDIAC DISCOMFORT 1 0.0005
254 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4 0.0005
255 CAPILLARY LEAK SYNDROME 1 0.0005
256 SKIN INDURATION 1 0.0005
257 CARDIOMYOPATHY 7 0.0005
258 VASCULAR OCCLUSION 1 0.0005
259 EAR SWELLING 1 0.0005
260 TEARFULNESS 2 0.0005
261 EXOPHTHALMOS 1 0.0005
262 HERPES SIMPLEX 3 0.0005
263 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
264 CORNEAL DISORDER 1 0.0005
265 CLOSTRIDIUM TEST POSITIVE 1 0.0005
266 DANDRUFF 1 0.0005
267 SKIN MASS 3 0.0004
268 BRAIN NEOPLASM MALIGNANT 2 0.0004
269 RASH 193 0.0004
270 PERIARTHRITIS 1 0.0004
271 IMMUNE THROMBOCYTOPENIA 2 0.0004
272 ERYTHEMA MULTIFORME 4 0.0004
273 PHOTOSENSITIVITY REACTION 7 0.0004
274 VARICELLA 1 0.0004
275 CHOLESTASIS 8 0.0004
276 THROMBOTIC MICROANGIOPATHY 4 0.0004
277 AUTOIMMUNE DISORDER 4 0.0004
278 HYPOPHOSPHATAEMIA 3 0.0004
279 STAPHYLOCOCCAL SEPSIS 2 0.0004
280 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1 0.0004
281 CORONARY ARTERY STENOSIS 2 0.0004
282 PLATELET DISORDER 1 0.0004
283 HAEMORRHAGE URINARY TRACT 1 0.0004
284 CANCER PAIN 1 0.0004
285 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
286 LUNG OPACITY 1 0.0004
287 RADICULOPATHY 1 0.0004
288 THERAPY NON-RESPONDER 17 0.0004
289 SKIN DISCOMFORT 1 0.0004
290 TACHYPNOEA 5 0.0004
291 LYMPHADENOPATHY 13 0.0004
292 ULCERATIVE KERATITIS 1 0.0004
293 RHINALGIA 1 0.0004
294 HYPERKERATOSIS 2 0.0004
295 CYTOMEGALOVIRUS INFECTION 6 0.0004
296 EOSINOPHIL COUNT INCREASED 3 0.0004
297 THERAPEUTIC RESPONSE DELAYED 1 0.0004
298 SKIN INFECTION 4 0.0004
299 SKIN HYPERTROPHY 1 0.0004
300 GENERALISED ERYTHEMA 2 0.0004
301 TUMOUR HAEMORRHAGE 1 0.0004
302 CHILLS 41 0.0003
303 PARAPLEGIA 1 0.0003
304 ENTEROCOLITIS 2 0.0003
305 WRONG PATIENT RECEIVED PRODUCT 1 0.0003
306 LYMPHOPROLIFERATIVE DISORDER 1 0.0003
307 DERMATITIS 7 0.0003
308 OROPHARYNGEAL DISCOMFORT 3 0.0003
309 HEPATITIS CHOLESTATIC 2 0.0003
310 MYELOFIBROSIS 1 0.0003
311 ADRENAL INSUFFICIENCY 4 0.0003
312 SEPTIC SHOCK 14 0.0003
313 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
314 BLOOD BLISTER 1 0.0003
315 HEPATITIS B REACTIVATION 1 0.0003
316 POLYMYALGIA RHEUMATICA 1 0.0003
317 RASH PAPULAR 7 0.0003
318 SKIN EROSION 1 0.0003
319 BACTERIAL SEPSIS 1 0.0003
320 THERAPY CHANGE 3 0.0003
321 OTITIS MEDIA 1 0.0003
322 INABILITY TO AFFORD MEDICATION 3 0.0003
323 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
324 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
325 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
326 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
327 BK VIRUS INFECTION 1 0.0003
328 SKIN EXFOLIATION 25 0.0003
329 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
330 B-CELL LYMPHOMA 1 0.0003
331 SUDDEN CARDIAC DEATH 1 0.0003
332 INTERSTITIAL LUNG DISEASE 14 0.0003
333 HYPERTRANSAMINASAEMIA 2 0.0003
334 ERYTHEMA NODOSUM 1 0.0003
335 PULMONARY TOXICITY 2 0.0003
336 HAEMORRHAGIC DIATHESIS 1 0.0003
337 CUTANEOUS VASCULITIS 1 0.0003
338 HEPATITIS 7 0.0003
339 SENSITIVE SKIN 2 0.0003
340 TRANSAMINASES INCREASED 6 0.0003
341 RETINOPATHY 1 0.0003
342 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
343 CATHETER SITE INFECTION 1 0.0003
344 TROPONIN INCREASED 2 0.0003
345 PAIN OF SKIN 7 0.0003
346 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
347 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
348 RASH MACULAR 9 0.0003
349 EJECTION FRACTION DECREASED 4 0.0003
350 PNEUMONITIS 7 0.0003
351 PNEUMONIA FUNGAL 1 0.0003
352 BACTERAEMIA 3 0.0003
353 SEPSIS 28 0.0003
354 RASH ERYTHEMATOUS 12 0.0003
355 BLEPHARITIS 1 0.0002
356 ORGAN FAILURE 1 0.0002
357 FUNGAL SKIN INFECTION 1 0.0002
358 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7 0.0002
359 CYTOPENIA 3 0.0002
360 GASTROINTESTINAL PERFORATION 1 0.0002
361 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
362 ONYCHOMADESIS 1 0.0002
363 POOR PERIPHERAL CIRCULATION 1 0.0002
364 DRUG RESISTANCE 6 0.0002
365 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 42 0.0002
366 SKIN HYPERPIGMENTATION 2 0.0002
367 NAIL DISORDER 2 0.0002
368 LYMPHOCYTE COUNT DECREASED 4 0.0002
369 UVEITIS 3 0.0002
370 HYPOTHYROIDISM 7 0.0002
371 EAR DISORDER 1 0.0002
372 IRON DEFICIENCY ANAEMIA 2 0.0002
373 MASS 3 0.0002
374 ROSACEA 1 0.0002
375 PERFORMANCE STATUS DECREASED 1 0.0002
376 BLISTER 12 0.0002
377 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
378 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
379 HYPOVOLAEMIC SHOCK 1 0.0002
380 SUBCUTANEOUS ABSCESS 1 0.0002
381 GUILLAIN-BARRE SYNDROME 1 0.0002
382 PANCREATIC DISORDER 1 0.0002
383 HOSPICE CARE 2 0.0002
384 HYPERNATRAEMIA 1 0.0002
385 CYTOKINE RELEASE SYNDROME 4 0.0002
386 ERYSIPELAS 1 0.0002
387 HYPOXIA 7 0.0002
388 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1 0.0002
389 SLUGGISHNESS 2 0.0002
390 FEMORAL NECK FRACTURE 1 0.0002
391 TEMPERATURE INTOLERANCE 2 0.0002
392 FOLLICULITIS 2 0.0002
393 SUDDEN DEATH 2 0.0002
394 COLITIS 7 0.0002
395 THERAPY INTERRUPTED 13 0.0002
396 ANAPHYLACTIC REACTION 10 0.0002
397 INFECTION 26 0.0002
398 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
399 INTESTINAL PERFORATION 2 0.0002
400 REBOUND EFFECT 2 0.0002
401 PRURITUS 68 0.0002
402 PERONEAL NERVE PALSY 1 0.0002
403 NEUTROPHILIA 1 0.0002
404 MYOCARDIAL ISCHAEMIA 2 0.0002
405 SCAB 2 0.0002
406 ERYTHEMA 36 0.0002
407 SKIN ATROPHY 1 0.0002
408 BLOOD URIC ACID INCREASED 1 0.0002
409 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
410 SKIN WARM 1 0.0002
411 EOSINOPHILIA 3 0.0002
412 HYPERTRIGLYCERIDAEMIA 1 0.0002
413 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
414 ENERGY INCREASED 1 0.0002
415 DISEASE RECURRENCE 8 0.0002
416 ODYNOPHAGIA 1 0.0002
417 HEPATITIS B 1 0.0002
418 C-REACTIVE PROTEIN INCREASED 6 0.0002
419 DERMATITIS ACNEIFORM 1 0.0002
420 CONJUNCTIVITIS 3 0.0002
421 GENERALISED OEDEMA 2 0.0002
422 BACTERIAL INFECTION 3 0.0002
423 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
424 SWELLING OF EYELID 1 0.0002
425 HYPOCALCAEMIA 3 0.0002
426 THERAPEUTIC RESPONSE CHANGED 1 0.0002
427 METABOLIC ACIDOSIS 5 0.0002
428 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
429 MUCOSAL INFLAMMATION 4 0.0002
430 ASPERGILLUS INFECTION 1 0.0002
431 HYPOGAMMAGLOBULINAEMIA 1 0.0002
432 IMMUNE SYSTEM DISORDER 2 0.0002
433 WALKING AID USER 1 0.0002
434 PANCREATITIS 8 0.0002
435 APPETITE DISORDER 1 0.0002
436 PYREXIA 52 0.0002
437 CARDIAC FAILURE ACUTE 1 0.0001
438 FUNGAL INFECTION 5 0.0001
439 RASH PRURITIC 8 0.0001
440 ONYCHOCLASIS 1 0.0001
441 LARGE INTESTINE POLYP 1 0.0001
442 RHABDOMYOLYSIS 6 0.0001
443 BLOOD TEST ABNORMAL 2 0.0001
444 SKIN REACTION 2 0.0001
445 PAPULE 1 0.0001
446 METASTASIS 1 0.0001
447 HYPERSOMNIA 4 0.0001
448 TONGUE DISORDER 1 0.0001
449 HYPERTHYROIDISM 2 0.0001
450 ALOPECIA 27 0.0001
451 APATHY 2 0.0001
452 MELAENA 3 0.0001
453 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
454 LIVER DISORDER 6 0.0001
455 CEREBRAL DISORDER 1 0.0001
456 ARTHROPOD BITE 1 0.0001
457 RASH MACULO-PAPULAR 3 0.0001
458 FEELING DRUNK 1 0.0001
459 PULMONARY MASS 2 0.0001
460 IMMUNODEFICIENCY 2 0.0001
461 THROMBOCYTOPENIA 15 0.0001
462 SUNBURN 1 0.0001
463 HEPATIC FAILURE 4 0.0001
464 LIPASE INCREASED 1 0.0001
465 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
466 FOOD ALLERGY 1 0.0001
467 TENDONITIS 2 0.0001
468 OEDEMA 7 0.0001
469 HYPOALBUMINAEMIA 1 0.0001
470 PULMONARY HAEMORRHAGE 1 0.0001
471 DRUG-INDUCED LIVER INJURY 4 0.0001
472 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
473 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
474 RENAL CYST 1 0.0001
475 PRODUCTIVE COUGH 6 0.0001
476 PANCYTOPENIA 7 0.0001
477 BLOOD DISORDER 1 0.0001
478 ACUTE KIDNEY INJURY 19 0.0001
479 DECUBITUS ULCER 1 0.0001
480 HICCUPS 1 0.0001
481 STAPHYLOCOCCAL INFECTION 4 0.0001
482 FEBRILE NEUTROPENIA 8 0.0001
483 AGEUSIA 3 0.0001
484 INFUSION SITE ERYTHEMA 1 0.0001
485 PSEUDOMONAS INFECTION 1 0.0001
486 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
487 BLOOD MAGNESIUM DECREASED 1 0.0001
488 SKIN SWELLING 1 0.0001
489 RESPIRATORY TRACT INFECTION 3 0.0001
490 ECZEMA 6 0.0001
491 BLOOD CALCIUM INCREASED 1 0.0001
492 GASTRITIS 3 0.0001
493 SPINAL OSTEOARTHRITIS 1 0.0001
494 LUNG INFILTRATION 1 0.0001
495 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
496 EAR INFECTION 3 0.0001
497 FACIAL PAIN 1 0.0001
498 COLITIS ULCERATIVE 5 0.0001
499 HAEMOLYTIC ANAEMIA 1 0.0001
500 ANAL INCONTINENCE 1 0.0001
501 LEUKOCYTOSIS 2 0.0001
502 LIP DRY 1 0.0001
503 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
504 ADVERSE EVENT 10 0.0001
505 RHINORRHOEA 7 0.0001
506 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
507 HEPATIC FUNCTION ABNORMAL 4 0.0001
508 NEPHROPATHY 1 0.0001
509 HEPATIC CIRRHOSIS 2 0.0001
510 SQUAMOUS CELL CARCINOMA 1 0.0001
511 PRODUCT USE IN UNAPPROVED INDICATION 26 0.0001
512 ACUTE RESPIRATORY FAILURE 2 0.0001
513 EAR PAIN 2 0.0001
514 SKIN FISSURES 2 0.0001
515 NASAL CONGESTION 6 0.0001
516 CONDITION AGGRAVATED 31 0.0001
517 KNEE OPERATION 1 0.0001
518 BODY TEMPERATURE DECREASED 1 0.0001
519 LEUKOPENIA 5 0.0001
520 BONE MARROW FAILURE 2 0.0001
521 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
522 POOR VENOUS ACCESS 1 0.0001
523 RESPIRATORY FAILURE 7 0.0001
524 PETECHIAE 1 0.0001
525 WEIGHT FLUCTUATION 1 0.0001
526 MUSCULOSKELETAL PAIN 5 0.0001
527 RENAL IMPAIRMENT 8 0.0001
528 SCRATCH 1 0.0001
529 NEUROPATHY PERIPHERAL 9 0.0001
530 CYSTITIS 3 0.0001
531 SKIN CANCER 2 0.0001
532 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
533 SWELLING FACE 6 0.0001
534 SKIN LACERATION 1 0.0001
535 OSTEONECROSIS 3 0.0001
536 ANGIOEDEMA 4 0.0001
537 VISUAL ACUITY REDUCED 3 0.0001
538 VENTRICULAR FIBRILLATION 1 0.0001
539 MALNUTRITION 1 0.0001
540 ORAL PAIN 2 0.0001
541 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
542 MYALGIA 15 0.0001
543 HEPATIC ENZYME INCREASED 6 0.0001
544 SKIN DISCOLOURATION 4 0.0001
545 SHOCK 2 0.0001
546 MADAROSIS 1 0.0001
547 RENAL DISORDER 4 0.0001
548 VASCULITIS 1 0.0001
549 HYPERKALAEMIA 3 0.0001
550 COVID-19 15 0.0001
551 ATAXIA 1 0.0001
552 PRODUCT PRESCRIBING ERROR 2 0.0001
553 CHOLECYSTITIS 1 0.0001
554 MYOCLONUS 1 0.0001
555 MYELOSUPPRESSION 3 0.0001
556 DRY SKIN 11 0.0001
557 NOCTURIA 1 0.0001
558 LIVER INJURY 2 0.0001
559 ENCEPHALOPATHY 2 0.0001
560 MUSCLE SPASTICITY 1 0.0001
561 TENDON RUPTURE 1 0.0001
562 PNEUMONIA ASPIRATION 2 0.0001
563 DERMATITIS ALLERGIC 1 0.0001
564 ANAEMIA 15 0.0001
565 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
566 INFLAMMATION 4 0.0001
567 SKIN ULCER 2 0.0001
568 DIPLOPIA 2 0.0001
569 PLATELET COUNT INCREASED 1 0.0001
570 NODULE 1 0.0001
571 BLOOD CREATININE INCREASED 5 0.0001
572 DEAFNESS 2 0.0001
573 ORAL CANDIDIASIS 1 0.0001
574 PULMONARY CONGESTION 1 0.0001
575 SOPOR 1 0.0001
576 QUALITY OF LIFE DECREASED 1 0.0001
577 SINUS CONGESTION 1 0.0001
578 PALLOR 2 0.0001
579 DIVERTICULITIS 2 0.0001
580 FEELING COLD 2 0.0001
581 APHONIA 1 0.0001
582 SLEEP DISORDER 5 0.0001
583 HEPATOCELLULAR INJURY 1 0.0001
584 CARDIOGENIC SHOCK 1 0.0001
585 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
586 LABORATORY TEST ABNORMAL 2 0.0001
587 SKIN HAEMORRHAGE 1 0.0001
588 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
589 ADVERSE DRUG REACTION 6 0.0001
590 NEUTROPENIA 9 0.0001
591 EPILEPSY 2 0.0001
592 INSURANCE ISSUE 1 0.0001
593 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
594 HOSPITALISATION 10 0.0001
595 DEVICE RELATED INFECTION 1 0.0001
596 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
597 THYROID DISORDER 1 0.0001
598 HYPOTENSION 13 0.0001
599 LYMPHOMA 1 0.0001
600 ACUTE MYELOID LEUKAEMIA 1 0.0001
601 DEATH 55 0.0001
602 FATIGUE 49 0.0001
603 ULCER 1 0.0001
604 SENSORY DISTURBANCE 1 0.0001
605 CARDIAC FAILURE 5 0.0001
606 NIGHT SWEATS 2 0.0001
607 MUSCLE TIGHTNESS 1 0.0001
608 BLOOD POTASSIUM INCREASED 1 0.0001
609 DEEP VEIN THROMBOSIS 4 0.0001
610 RENAL FAILURE 8 0.0001
611 VIRAL INFECTION 2 0.0001
612 CIRCULATORY COLLAPSE 1 0.0001
613 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
614 NEOPLASM PROGRESSION 2 0.0001
615 ORTHOSTATIC HYPOTENSION 1 0.0001
616 MALAISE 25 0.0001
617 HEART RATE DECREASED 2 0.0001
618 DEPRESSED MOOD 3 0.0001
619 COLD SWEAT 1 0.0001
620 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
621 TACHYCARDIA 5 0.0001
622 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
623 ISCHAEMIC STROKE 1 0.0001
624 THIRST 1 0.0001
625 OSTEOMYELITIS 1 0.0001
626 HYPERGLYCAEMIA 2 0.0001
627 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
628 PRODUCT DOSE OMISSION ISSUE 16 0.0001
629 DYSURIA 2 0.0001
630 THINKING ABNORMAL 1 0.0001
631 OXYGEN SATURATION DECREASED 3 0.0001
632 TOXICITY TO VARIOUS AGENTS 9 0.0001
633 MUSCULAR WEAKNESS 6 0.0001
634 BLOOD URINE PRESENT 1 0.0001
635 PULMONARY EMBOLISM 5 0.0001
636 HERPES ZOSTER 3 0.0001
637 CONTUSION 5 0.0001
638 DECREASED APPETITE 12 0.0001
639 ORAL HERPES 1 0.0001
640 PARAESTHESIA 8 0.0001
641 WHEEZING 3 0.0001
642 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
643 SOMNOLENCE 10 0.0000
644 DIARRHOEA 32 0.0000
645 STOMATITIS 3 0.0000
646 ILL-DEFINED DISORDER 3 0.0000
647 FEEDING DISORDER 1 0.0000
648 DRY MOUTH 4 0.0000
649 VERTIGO 3 0.0000
650 FLUSHING 5 0.0000
651 BODY TEMPERATURE INCREASED 1 0.0000
652 LUNG NEOPLASM MALIGNANT 2 0.0000
653 ILLNESS 5 0.0000
654 CARDIO-RESPIRATORY ARREST 2 0.0000
655 MOUTH ULCERATION 1 0.0000
656 PLATELET COUNT DECREASED 5 0.0000
657 LIVER FUNCTION TEST INCREASED 1 0.0000
658 POOR QUALITY SLEEP 1 0.0000
659 PRURITUS GENERALISED 1 0.0000
660 PSORIASIS 6 0.0000
661 HEPATOTOXICITY 1 0.0000
662 PANCREATITIS ACUTE 1 0.0000
663 HYPOKALAEMIA 2 0.0000
664 PNEUMONIA 14 0.0000
665 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
666 NAUSEA 34 0.0000
667 COGNITIVE DISORDER 2 0.0000
668 BURNING SENSATION 3 0.0000
669 CARDIAC DISORDER 4 0.0000
670 DYSPNOEA 24 0.0000
671 OCULAR HYPERAEMIA 2 0.0000
672 DYSPHAGIA 4 0.0000
673 SKIN BURNING SENSATION 3 0.0000
674 MOBILITY DECREASED 3 0.0000
675 HEPATIC CANCER 1 0.0000
676 PRESYNCOPE 1 0.0000
677 ATRIAL FIBRILLATION 4 0.0000
678 LUNG DISORDER 2 0.0000
679 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
680 SYNCOPE 4 0.0000
681 CELLULITIS 2 0.0000
682 GASTRIC CANCER 1 0.0000
683 DIABETES MELLITUS 3 0.0000
684 BLOOD PRESSURE INCREASED 6 0.0000
685 THERAPY CESSATION 2 0.0000
686 ERECTILE DYSFUNCTION 1 0.0000
687 ANAPHYLACTIC SHOCK 1 0.0000
688 UNRESPONSIVE TO STIMULI 1 0.0000
689 RASH GENERALISED 1 0.0000
690 ARTHRITIS 3 0.0000
691 DRUG INTERACTION 6 0.0000
692 CHEST PAIN 7 0.0000
693 HYPERSENSITIVITY 7 0.0000
694 OFF LABEL USE 33 0.0000
695 DEHYDRATION 5 0.0000
696 ASTHENIA 14 0.0000
697 BLOOD BILIRUBIN INCREASED 1 0.0000
698 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
699 LIMB INJURY 1 0.0000
700 TREMOR 6 0.0000
701 PROCEDURAL PAIN 1 0.0000
702 ARTHROPATHY 2 0.0000
703 DEMENTIA 1 0.0000
704 WEIGHT INCREASED 8 0.0000
705 INTENTIONAL DOSE OMISSION 1 0.0000
706 ANGINA PECTORIS 1 0.0000
707 LETHARGY 2 0.0000
708 BALANCE DISORDER 3 0.0000
709 BACK PAIN 8 0.0000
710 DYSPHONIA 2 0.0000
711 BLADDER CANCER 2 0.0000
712 RESPIRATORY DISORDER 1 0.0000
713 EMOTIONAL DISTRESS 4 0.0000
714 PERIPHERAL SWELLING 5 0.0000
715 FEMUR FRACTURE 1 0.0000
716 COUGH 9 0.0000
717 VOMITING 15 0.0000
718 MOOD SWINGS 1 0.0000
719 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
720 BLOOD PRESSURE DECREASED 2 0.0000
721 LIP SWELLING 1 0.0000
722 URINARY RETENTION 1 0.0000
723 NEOPLASM MALIGNANT 2 0.0000
724 CHEST DISCOMFORT 3 0.0000
725 GASTRIC DISORDER 1 0.0000
726 NIGHTMARE 1 0.0000
727 DELIRIUM 1 0.0000
728 ABDOMINAL DISTENSION 3 0.0000
729 DRUG INEFFECTIVE 37 0.0000
730 CEREBRAL HAEMORRHAGE 1 0.0000
731 CRYING 1 0.0000
732 CONSTIPATION 6 0.0000
733 PANIC ATTACK 1 0.0000
734 PAIN IN EXTREMITY 8 0.0000
735 HEADACHE 17 0.0000
736 EYE SWELLING 1 0.0000
737 DYSPNOEA EXERTIONAL 1 0.0000
738 HOT FLUSH 2 0.0000
739 ARTHRALGIA 11 0.0000
740 ACNE 2 0.0000
741 ABNORMAL BEHAVIOUR 1 0.0000
742 FEELING ABNORMAL 6 0.0000
743 CARDIAC FAILURE CONGESTIVE 2 0.0000
744 THROMBOSIS 2 0.0000
745 OEDEMA PERIPHERAL 3 0.0000
746 PAIN 15 0.0000
747 TREATMENT FAILURE 2 0.0000
748 DIZZINESS 12 0.0000
749 HYPERTENSION 5 0.0000
750 LOSS OF CONSCIOUSNESS 3 0.0000
751 MENTAL DISORDER 1 0.0000
752 PULMONARY OEDEMA 1 0.0000
753 SKIN IRRITATION 1 0.0000
754 NEPHROLITHIASIS 1 0.0000
755 MUSCLE SPASMS 4 0.0000
756 TINNITUS 1 0.0000
757 SWELLING 2 0.0000
758 ARRHYTHMIA 1 0.0000
759 FALL 7 0.0000
760 DRUG INTOLERANCE 2 0.0000
761 HYPOAESTHESIA 3 0.0000
762 FLUID RETENTION 1 0.0000
763 HAEMOGLOBIN DECREASED 2 0.0000
764 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
765 NERVOUSNESS 1 0.0000
766 SPEECH DISORDER 1 0.0000
767 INSOMNIA 5 0.0000
768 HAEMATOCHEZIA 1 0.0000
769 WEIGHT DECREASED 5 0.0000
770 URTICARIA 3 0.0000
771 HYPONATRAEMIA 1 0.0000
772 EYE PAIN 1 0.0000
773 RHEUMATOID ARTHRITIS 2 0.0000
774 URINARY TRACT INFECTION 3 0.0000
775 BONE PAIN 1 0.0000
776 SURGERY 1 0.0000
777 CATARACT 1 0.0000
778 JOINT SWELLING 2 0.0000
779 PLEURAL EFFUSION 1 0.0000
780 DISCOMFORT 1 0.0000
781 FEELING HOT 1 0.0000
782 GAIT DISTURBANCE 3 0.0000
783 HYPERHIDROSIS 2 0.0000
784 PRODUCT DOSE OMISSION 1 0.0000
785 VISION BLURRED 2 0.0000
786 INJURY 1 0.0000
787 ANXIETY 4 0.0000
788 DYSGEUSIA 1 0.0000
789 UNEVALUABLE EVENT 1 0.0000
790 CHRONIC KIDNEY DISEASE 1 0.0000
791 CARDIAC ARREST 1 0.0000
792 DRUG ABUSE 1 0.0000
793 CEREBROVASCULAR ACCIDENT 2 0.0000
794 MYOCARDIAL INFARCTION 2 0.0000
795 INTENTIONAL PRODUCT MISUSE 1 0.0000
796 MUSCULOSKELETAL STIFFNESS 1 0.0000
797 GASTROINTESTINAL DISORDER 1 0.0000
798 NO ADVERSE EVENT 2 0.0000
799 SUICIDAL IDEATION 1 0.0000
800 OROPHARYNGEAL PAIN 1 0.0000
801 MIGRAINE 1 0.0000
802 SINUSITIS 1 0.0000
803 ABDOMINAL PAIN UPPER 2 0.0000
804 DEPRESSION 2 0.0000
805 ABDOMINAL PAIN 2 0.0000
806 PALPITATIONS 1 0.0000
807 MEMORY IMPAIRMENT 1 0.0000
808 CONFUSIONAL STATE 1 0.0000
809 ABDOMINAL DISCOMFORT 1 0.0000
810 NASOPHARYNGITIS 1 0.0000
811 PRODUCT USE ISSUE 1 0.0000
812 INCORRECT DOSE ADMINISTERED 1 0.0000